Chios mastic treatment of patients with active Crohn's disease.
about
A review of the efficacy of traditional Iranian medicine for inflammatory bowel diseaseHerbal and plant therapy in patients with inflammatory bowel diseaseFive Pistacia species (P. vera, P. atlantica, P. terebinthus, P. khinjuk, and P. lentiscus): a review of their traditional uses, phytochemistry, and pharmacologyCamphene, a plant-derived monoterpene, reduces plasma cholesterol and triglycerides in hyperlipidemic rats independently of HMG-CoA reductase activityPotential role of nutraceutical compounds in inflammatory bowel diseaseAlterations in the function of circulating mononuclear cells derived from patients with Crohn's disease treated with mastic.A mechanistic review on plant-derived natural compounds as dietary supplements for prevention of inflammatory bowel disease.Promising effect of Magliasa, a traditional Iranian formula, on experimental colitis on the basis of biochemical and cellular findings.On the use of herbal medicines in management of inflammatory bowel diseases: a systematic review of animal and human studies.Traditional Persian topical medications for gastrointestinal diseases.Mastic oil inhibits the metastatic phenotype of mouse lung adenocarcinoma cellsAntioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal.Gene-Diet Interactions on Colorectal Cancer RiskBioavailability of Terpenes and Postprandial Effect on Human Antioxidant Potential. An Open-Label Study in Healthy Subjects.Drug-Herb Interactions in the Elderly Patient with IBD: a Growing Concern.Anti-inflammatory effect of elemental diets with different fat composition in experimental colitis.Development and Validation of a Multi-residue Method for the Determination of Pesticides in Chios Mastic Gum by QuEChERS and Liquid Chromatography–Tandem Mass Spectrometry
P2860
Q24601108-7C9ADC80-C672-45A8-B062-809C9A9CC195Q26823835-42DB26D7-B75F-4296-A43B-6CEB2448D0B9Q26824201-74D92AE9-C262-4CD7-9AB6-B1646DD377B4Q28743164-B23785BC-8ACB-4985-BE78-CAB0B27819D5Q33572633-3436F1B0-2835-4340-9A5A-DB040C618152Q34606228-3D8CF43B-210D-4F68-99C2-490317738BE5Q35901531-60939E90-954F-4CA0-954B-D7A5B8851224Q36731168-FFE76568-3763-4F99-B55C-3A13F960D51BQ37212833-ED0C7BA4-C08E-4FEC-85D5-7C6FEF5BA31FQ38845246-CE46E299-4FC6-4E1B-94F2-E2D5A3824382Q42575759-D06CDC51-916A-4C6C-BA9A-F1F1542D0323Q42756142-5438230A-6814-4321-BCAD-4094BCB80926Q42775534-2DFF81FA-7AAC-4257-AC83-C0A5B80FDC82Q47783327-F34BFBAF-B932-4635-8198-3A54399630A4Q50055464-D7FADBAB-4206-4ADD-B83A-14CBCA9DDFFAQ54601212-94A08D58-9115-4748-A65F-A6AB8D249E36Q59279332-CA1BE81D-E589-486E-A068-8A728B6C1D0C
P2860
Chios mastic treatment of patients with active Crohn's disease.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Chios mastic treatment of patients with active Crohn's disease.
@ast
Chios mastic treatment of patients with active Crohn's disease.
@en
type
label
Chios mastic treatment of patients with active Crohn's disease.
@ast
Chios mastic treatment of patients with active Crohn's disease.
@en
prefLabel
Chios mastic treatment of patients with active Crohn's disease.
@ast
Chios mastic treatment of patients with active Crohn's disease.
@en
P2093
P2860
P356
P1476
Chios mastic treatment of patients with active Crohn's disease.
@en
P2093
Andriana C Kaliora
George V Z Dedoussis
John K Triantafillidis
Maria G Stathopoulou
Nikolaos K Andrikopoulos
P2860
P304
P356
10.3748/WJG.V13.I5.748
P407
P577
2007-02-01T00:00:00Z